Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (221-230 of 350) with videos related to

Pageof 35
Sort By:
Clinical Immunology and Immunopathology|August 1, 1982
The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patientsM Talpaz, J E Medina, Y Z Patt, et al.
Acta Haematologica|January 1, 1987
Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemiaH M Kantarjian, M Talpaz, R Kurzrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Second cancer risk in hairy cell leukemia: analysis of 350 patientsR Kurzrock, S S Strom, E Estey, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Blood|April 15, 1992
Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapyM S Lee, H Kantarjian, M Talpaz, et al.
Leukemia|August 1, 1992
Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reactionK Dhingra, R Kurzrock, H Kantarjian, et al.
The American Journal of Medicine|January 1, 1993
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosisP M Derderian, H M Kantarjian, M Talpaz, et al.
Leukemia|March 31, 1998
Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferonT Oka, K J Sastry, P Nehete, et al.
British Journal of Haematology|December 1, 1992
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantationM Lee, I Khouri, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, M Talpaz, S O'Brien, et al.
Pageof 35

Showing results (221-230 of 350) with videos related to

Sort By:
Pageof 35
Clinical Immunology and Immunopathology|August 1, 1982
The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patientsM Talpaz, J E Medina, Y Z Patt, et al.
Acta Haematologica|January 1, 1987
Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemiaH M Kantarjian, M Talpaz, R Kurzrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Second cancer risk in hairy cell leukemia: analysis of 350 patientsR Kurzrock, S S Strom, E Estey, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Blood|April 15, 1992
Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapyM S Lee, H Kantarjian, M Talpaz, et al.
Leukemia|August 1, 1992
Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reactionK Dhingra, R Kurzrock, H Kantarjian, et al.
The American Journal of Medicine|January 1, 1993
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosisP M Derderian, H M Kantarjian, M Talpaz, et al.
Leukemia|March 31, 1998
Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferonT Oka, K J Sastry, P Nehete, et al.
British Journal of Haematology|December 1, 1992
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantationM Lee, I Khouri, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, M Talpaz, S O'Brien, et al.
Pageof 35